Si-Bone (SIBN) Net Cash Flow (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -154.24% |
| Dec 31, 2025 | 305.53% |
| Sep 30, 2025 | -8.69% |
| Jun 30, 2025 | -221.35% |
| Mar 31, 2025 | 7.08% |
| Dec 31, 2024 | 28.66% |
| Sep 30, 2024 | 166.16% |
| Jun 30, 2024 | -470.87% |
| Mar 31, 2024 | 94.51% |
| Dec 31, 2023 | 64.38% |
| Sep 30, 2023 | -165.11% |
| Jun 30, 2023 | 3,974.90% |
| Mar 31, 2023 | 135.96% |
| Dec 31, 2022 | -359.89% |
| Sep 30, 2022 | 187.51% |
| Jun 30, 2022 | 92.67% |
| Mar 31, 2022 | -1,077.19% |
| Dec 31, 2021 | -69.09% |
| Sep 30, 2021 | 11.89% |
| Jun 30, 2021 | 166.98% |
| Mar 31, 2021 | -496.32% |
| Dec 31, 2020 | 74.00% |
| Sep 30, 2020 | -627.41% |
| Jun 30, 2020 | -102.46% |
| Mar 31, 2020 | 2,690.03% |
| Dec 31, 2019 | -287.27% |
| Sep 30, 2019 | 205.75% |
| Jun 30, 2019 | 91.09% |
| Mar 31, 2019 | -212.08% |
| Dec 31, 2018 | 613.72% |
| Sep 30, 2018 | -38.26% |
| Jun 30, 2018 | 65.91% |
| Mar 31, 2018 | -204.56% |